CHV-NEO: Community-based Digital Communication to Support Neonatal Health

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexFemale
Age14+
SponsorUniversity of Washington

About this trial

Neonatal mortality (defined as death in the first 28 days of life) remains unacceptably high in sub-Sarahan Africa. The concentrated risk of neonatal illness in the first weeks of life and its potential to rapidly deteriorate means that expanding mothers' access to timely information and support during this period is critical to reducing neonatal mortality. This cluster-randomized control trial aims to integrate a 2 way interactive SMS text messaging intervention into existing digital infrastructure supporting Community Health Volunteer (CHV) workflow in Western Kenya (dCHT) to enable remote communication by mothers with CHVs between home visits.

Eligibility criteria

Qualifiers

Pregnant

26-36 weeks gestation

Daily access to a mobile phone (own or shared)

Willing to receive SMS

Disqualifiers

participating in another study

previously participated in this study

Trial design

Treatments tested in this trial

  • CHV-NEO

Treatment groups

3,000 Participants
are divided into 2 treatment groups

Sponsors and collaborators

University of Washington

Lead sponsor

Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

Collaborator

BRAC University

Collaborator

Bill and Melinda Gates Foundation

Collaborator